Baxter International (BAX) Income from Non-Controlling Interests (2009 - 2024)
Baxter International (BAX) posted quarterly Income from Non-Controlling Interests of $2.0 million for Q4 2024, up 100.0% year-over-year from $1.0 million in Q1 2024, and down 50.0% quarter-over-quarter from $4.0 million in Q3 2024.
Baxter International (BAX) Income from Non-Controlling Interests (2009 - 2024) Analysis & Trends
Baxter International (BAX) has reported Income from Non-Controlling Interests for 9 consecutive years, with $2.0 million the latest figure, recorded in Q4 2024.
- In Q4 2024, Income from Non-Controlling Interests rose 100.0% year-over-year to $2.0 million; the TTM figure through Sep 2025 stood at $2.0 million (down 50.0% YoY), while the FY2024 annual figure was $11.0 million, up 57.14% from the prior year.
- Income from Non-Controlling Interests slipped to $2.0 million in Q4 2024 per BAX's latest filing, from $4.0 million in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at $4.0 million in Q4 2021 and bottomed at -$4.0 million in Q1 2024.
- Historically, Income from Non-Controlling Interests has averaged $2.2 million across 5 years, with a median of $2.5 million in 2020.
- Annual changes were most pronounced in 2021 — Income from Non-Controlling Interests jumped 200.0% — and 2024, when it sank 500.0%.
- Baxter International's Income from Non-Controlling Interests stood at $3.0 million in 2020, then jumped by 33.33% to $4.0 million in 2021, then changed by 0.0% to $4.0 million in 2022, then slumped by 75.0% to $1.0 million in 2023, then surged by 100.0% to $2.0 million in 2024.
- Business Quant data shows BAX's Income from Non-Controlling Interests at $2.0 million in Q4 2024, $4.0 million in Q3 2024, and $3.0 million in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 6.60 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | - |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 79.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | - |
| 10 | Align Technology | 11.61 Bn | 10.51 Bn | 757.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 2.00 Mn |
| Mar 31, 2024 | 2.00 Mn |
| Dec 31, 2023 | -6.00 Mn |
| Sep 30, 2023 | 3.00 Mn |
| Jun 30, 2023 | 2.00 Mn |
| Mar 31, 2023 | 1.00 Mn |
| Dec 31, 2022 | 4.00 Mn |
| Sep 30, 2022 | 3.00 Mn |
| Jun 30, 2022 | 3.00 Mn |
| Mar 31, 2022 | 2.00 Mn |
| Dec 31, 2021 | 4.00 Mn |
| Sep 30, 2021 | 2.00 Mn |
| Jun 30, 2021 | 3.00 Mn |
| Mar 31, 2021 | 2.00 Mn |
| Dec 31, 2020 | 3.00 Mn |
| Sep 30, 2020 | 3.00 Mn |
| Jun 30, 2020 | 1.00 Mn |
| Mar 31, 2020 | 1.00 Mn |
| Dec 31, 2019 | 4.00 Mn |
| Sep 30, 2019 | 6.00 Mn |